Skip to content

The optimized scheme of Acupuncture treatment on symptom based Stroke Sequeland clinical assessment on generic technology

The optimized scheme of Acupuncture treatment on symptom based Stroke Sequeland clinical assessment on generic technology

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-08000209
Enrollment
Unknown
Registered
2008-11-28
Start date
2008-06-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Infarction

Interventions

Group B:Rehabilitation
Group C:Rehabilitation

Sponsors

The Ministry of Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. according to Diagnostic Criteria of Cerebral Infarction of Apoplectic disease by western medicine; 2. according to Diagnostic Criteria of Apoplectic disease by TCM; 3. cerebrovascular accident. occurred in internal carotid artery system, proved by head CT or MRI; 4. attacked by stroke 1 or 2 times (almostly recovered from the first time), the pathogenic time of this time is 15-90 days; 5. age 40-75, both males and females; 6. In NDS, the score of limb function defect>=10; 7. The patient is self-conscious, vital signs is stable; 8. Informed and Consent.

Exclusion criteria

Exclusion criteria: 1. TIA, RIND, etc.; 2. It was test proved that the patients' neurological deficit was caused by Brain Tumor, Brain Injury, brain parasitic disease, cardiac disease, dysbolism, etc. Patients with Hemorrhagic Cerebrovascular Disease; 3. Women in pregnancy or lactation period; 4. Accordance with severe primary diseases in heart, liver, kidney, hemopoietic System and endocrine system, psychotic patient.

Design outcomes

Primary

MeasureTime frame
Neurological deficits scores;Motive function;Ability of daily life;

Secondary

MeasureTime frame
Total function assessment;Based on clinical outcome assessment of the report;Adverse event;

Countries

China

Contacts

Public ContactGuirong Dong
dongguirong@tom.com+86 0 13162675069

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026